Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Propeller Health

Novartis building

Novartis says Afinitor fails liver cancer trial

Halts plans to file for approval in new indication

iPad detailing: still room for pharma to improve

Doctors want to be 'wowed', and video is where iPads shine, says Manhattan Research

- PMLiVE

Boehringer’s first cancer drug leads EMA recommendations

Afatinib recommended for lung cancer under brand name Giotrif

Sanofi Israel crowdsources new diabetes app

Collaborates with online patient network Camoni

Boehringer trials digital diabetes programme

Will study effect of self-management technology on clinical care

Novartis building

Novartis lifts 2013 guidance on delay to Diovan generics

Reveals scale of payments to former CEO Daniel Vasella

Novartis sponsors rare disease patient community

Backs site for patients affected by pancreatic neuroendocrine tumours (PNET)

- PMLiVE

Novartis enters developing nations vaccines partnership

Will work with Biological E to deliver vaccines for typhoid and paratyphoid A fevers

Novartis building

Novartis’ secukinumab tops Enbrel in psoriasis study

Phase III results show the antibody is more effective than Amgen/Pfizer's blockbuster

Pharmacists need the right mobile tools

Alliance Boots' Kash Mahmood outlines digital opportunities for pharmacy

Novartis day

Lucentis cleared in Europe for pathological myopia

Makes Novartis' drug the first anti-VEGF approved in this setting

mHealth: patients open to app prescriptions

Study suggests patients want to use technology to self-manage

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links